MariMed Inc MRMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MRMD is a good fit for your portfolio.
News
-
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
-
MariMed Partners with Iconic Boston Music Venues
-
MariMed Closes Acquisition of Second Maryland Dispensary
-
MariMed Announces First Quarter 2024 Earnings Date
-
A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois
-
MariMed Reports Fourth Quarter and Full Year 2023 Earnings
-
MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep
-
MariMed Introduces New and Improved Vibations™ Cannabis and Electrolyte Drink Mix
Trading Information
- Previous Close Price
- $0.26
- Day Range
- $0.26–0.27
- 52-Week Range
- $0.20–0.55
- Bid/Ask
- $0.25 / $0.27
- Market Cap
- $100.23 Mil
- Volume/Avg
- 126,577 / 468,509
Key Statistics
- Price/Earnings (Normalized)
- 28.55
- Price/Sales
- 0.63
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees and Licensing fees.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 742
- Website
- https://www.marimedinc.com
Comparables
Valuation
|
Metric
|
MRMD
|
TRUL
|
CL
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.55 | 65.65 | — |
Price/Book Value | 1.34 | 1.47 | 1.43 |
Price/Sales | 0.63 | 1.84 | 0.88 |
Price/Cash Flow | 10.12 | 74.93 | 15.60 |
Price/Earnings
MRMD
TRUL
CL
Financial Strength
|
Metric
|
MRMD
|
TRUL
|
CL
|
|---|---|---|---|
Quick Ratio | 0.74 | 1.87 | 0.78 |
Current Ratio | 1.67 | 4.16 | 1.39 |
Interest Coverage | 0.25 | −2.56 | −1.36 |
Quick Ratio
MRMD
TRUL
CL
Profitability
|
Metric
|
MRMD
|
TRUL
|
CL
|
|---|---|---|---|
Return on Assets (Normalized) | −2.95% | −3.80% | −3.12% |
Return on Equity (Normalized) | −7.45% | −7.03% | −8.02% |
Return on Invested Capital (Normalized) | 1.25% | −2.14% | −0.11% |
Return on Assets
MRMD
TRUL
CL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hpkmjwkhx | Nlxtldk | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Cskysflwwt | Vgrj | $68.9 Bil | |
HLN
| Haleon PLC ADR | Dwkgytmwb | Wmcf | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wsfxclmk | Vdjrp | $14.8 Bil | |
VTRS
| Viatris Inc | Fjpddgrn | Kxqbj | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rjjjtlpk | Wyxf | $11.9 Bil | |
CTLT
| Catalent Inc | Yhvbfrm | Bllqwh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bbysrgfw | Nfgc | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Wkskhky | Lndn | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Zngfcyqk | Nclshy | $3.5 Bil |